MAIA Biotechnology, Inc. (MAIA)
(Delayed Data from AMEX)
$1.52 USD
-0.06 (-3.80%)
Updated Aug 6, 2025 03:59 PM ET
After-Market: $1.52 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MAIA 1.52 -0.06(-3.80%)
Will MAIA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MAIA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MAIA
Best Momentum Stocks to Buy for May 6th
New Strong Buy Stocks for May 6th
MAIA: What are Zacks experts saying now?
Zacks Private Portfolio Services
MAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should Know
Other News for MAIA
MAIA Secures FDA Fast Track for Lung Cancer Treatment
MAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine as a Treatment for ...
MAIA Biotechnology granted fast track designation for ateganosine
MAIA Biotechnology Publishes Groundbreaking Preclinical Data | MAIA Stock News
MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second ...